91³Ô¹Ï

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
91³Ô¹Ï

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 4334

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Orthosiphon stamineus improves cognitive functions after ICV streptozotocin insult in alzheimer�s disease model

10th World Congress on Alzheimer's Disease & Dementia

Thaarvena Retinasamy

Monash University Malaysia Campus, Malaysia

Posters & Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI:

Abstract
Alzheimer�s disease is a chronic neurodegenerative disease that causes cognitive impairment like learning and memory. Orthosiphon stamineus (OS) is a medicinal herb that has been reported to exert various pharmacological activities. The objective of this study was to evaluate whether this Malaysian plant extract can reverse Streptozotocin (STZ) induced cognitive dysfunction in experimental animals. Rats were subjected to Intra Cerebro Ventricular (ICV) injections of STZ (3 mg/kg) bilaterally. The STZ-injected rats received oral treatment of OS (50,100 and 200 mg/kg) one day after the surgery, for 7 days before being subjected to behavioral analysis. The learning and memory performance was assessed using passive avoidance and elevated plus maze tests. It was found that the OS administration significantly attenuated learning and memory impairment induced by STZ-injection. The hippocampal tissues were extracted for gene expression analysis, known to be modulated in AD condition. All the three doses demonstrated effectiveness against Scopolamine-induced cognitive impairment when compared to the negative control group. Therefore, these results demonstrate the effectiveness of OS in averting cognitive deficits could serve as a potential therapeutic option for the treatment of neurodegenerative diseases like AD. thaarvena@gmail.com
Biography
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top